United States - English - NLM (National Library of Medicine)

e. fougera & co. a division of fougera pharmaceuticals inc. - tacrolimus (unii: wm0haq4wnm) (tacrolimus anhydrous - unii:y5l2157c4j) - tacrolimus anhydrous 1 mg in 1 g - tacrolimus ointment, both 0.03% and 0.1% for adults, and only 0.03% for children aged 2 to 15 years, is indicated as second-line therapy for the short-term and non-continuous chronic treatment of moderate to severe atopic dermatitis in non-immunocompromised adults and children who have failed to respond adequately to other topical prescription treatments for atopic dermatitis, or when those treatments are not advisable. tacrolimus ointment is not indicated for children younger than 2 years of age (see boxed warning , warnings and precautions: pediatric use ). tacrolimus ointment is contraindicated in patients with a history of hypersensitivity to tacrolimus or any other component of the ointment.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - tacrolimus monohydrate, quantity: 5.112 mg (equivalent: tacrolimus, qty 5 mg) - capsule, modified release - excipient ingredients: ethylcellulose; hypromellose; lactose monohydrate; magnesium stearate; sunset yellow fcf; allura red ac; brilliant blue fcf; titanium dioxide; gelatin; propylene glycol; butan-1-ol; sunset yellow fcf aluminium lake; isopropyl alcohol; brilliant blue fcf aluminium lake; allura red ac aluminium lake; lecithin; simethicone; ethanol; shellac; strong ammonia solution; sulfuric acid - tacrolimus xr sandoz are indicated for use as an adjunct to liver, kidney, lung or heart allograft transplantation in adults and children.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - tacrolimus monohydrate, quantity: 3.067 mg (equivalent: tacrolimus, qty 3 mg) - capsule, modified release - excipient ingredients: ethylcellulose; hypromellose; lactose monohydrate; magnesium stearate; sunset yellow fcf; allura red ac; brilliant blue fcf; titanium dioxide; gelatin; propylene glycol; butan-1-ol; sunset yellow fcf aluminium lake; isopropyl alcohol; brilliant blue fcf aluminium lake; allura red ac aluminium lake; lecithin; simethicone; ethanol; shellac; strong ammonia solution; sulfuric acid - tacrolimus xr sandoz are indicated for use as an adjunct to liver, kidney, lung or heart allograft transplantation in adults and children.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - tacrolimus monohydrate, quantity: 2.045 mg (equivalent: tacrolimus, qty 2 mg) - capsule, modified release - excipient ingredients: ethylcellulose; hypromellose; lactose monohydrate; magnesium stearate; sunset yellow fcf; allura red ac; brilliant blue fcf; titanium dioxide; gelatin; tartrazine; propylene glycol; butan-1-ol; sunset yellow fcf aluminium lake; isopropyl alcohol; brilliant blue fcf aluminium lake; allura red ac aluminium lake; lecithin; simethicone; ethanol; shellac; strong ammonia solution; sulfuric acid - tacrolimus xr sandoz are indicated for use as an adjunct to liver, kidney, lung or heart allograft transplantation in adults and children.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - tacrolimus monohydrate, quantity: 1.022 mg (equivalent: tacrolimus, qty 1 mg) - capsule, modified release - excipient ingredients: ethylcellulose; hypromellose; lactose monohydrate; magnesium stearate; sunset yellow fcf; allura red ac; brilliant blue fcf; titanium dioxide; gelatin; propylene glycol; butan-1-ol; sunset yellow fcf aluminium lake; isopropyl alcohol; brilliant blue fcf aluminium lake; allura red ac aluminium lake; lecithin; simethicone; ethanol; shellac; strong ammonia solution; sulfuric acid - tacrolimus xr sandoz are indicated for use as an adjunct to liver, kidney, lung or heart allograft transplantation in adults and children.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - tacrolimus monohydrate, quantity: 0.511 mg (equivalent: tacrolimus, qty 0.5 mg) - capsule, modified release - excipient ingredients: ethylcellulose; hypromellose; lactose monohydrate; magnesium stearate; sunset yellow fcf; allura red ac; brilliant blue fcf; titanium dioxide; gelatin; tartrazine; propylene glycol; butan-1-ol; sunset yellow fcf aluminium lake; isopropyl alcohol; brilliant blue fcf aluminium lake; allura red ac aluminium lake; lecithin; simethicone; ethanol; shellac; strong ammonia solution; sulfuric acid - tacrolimus xr sandoz are indicated for use as an adjunct to liver, kidney, lung or heart allograft transplantation in adults and children.

United States - English - NLM (National Library of Medicine)

padagis israel pharmaceuticals ltd - tacrolimus (unii: wm0haq4wnm) (tacrolimus anhydrous - unii:y5l2157c4j) - tacrolimus anhydrous 0.3 mg in 1 g - tacrolimus ointment, both 0.03% and 0.1% for adults, and only 0.03% for children aged 2 to 15 years, is indicated as second-line therapy for the short-term and non-continuous chronic treatment of moderate to severe atopic dermatitis in non-immunocompromised adults and children who have failed to respond adequately to other topical prescription treatments for atopic dermatitis, or when those treatments are not advisable. tacrolimus ointment is not indicated for children younger than 2 years of age (see boxed warning, warnings and precautions: pediatric use). tacrolimus ointment is contraindicated in patients with a history of hypersensitivity to tacrolimus or any other component of the ointment.

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - tacrolimus monohydrate, quantity: 1.02 mg (equivalent: tacrolimus, qty 1 mg) - capsule - excipient ingredients: hypromellose; dichloromethane; lactose; ethanol absolute; magnesium stearate; croscarmellose sodium; titanium dioxide; purified water; gelatin; sodium lauryl sulfate - tacrolimus is indicated for use as an adjunct to liver, kidney, lung or heart allograft transplantation in adults and children.

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - tacrolimus monohydrate, quantity: 0.51 mg (equivalent: tacrolimus, qty 0.5 mg) - capsule - excipient ingredients: dichloromethane; lactose; ethanol absolute; magnesium stearate; croscarmellose sodium; hypromellose; titanium dioxide; purified water; iron oxide yellow; gelatin; sodium lauryl sulfate - tacrolimus is indicated for use as an adjunct to liver, kidney, lung or heart allograft transplantation in adults and children.

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - tacrolimus monohydrate, quantity: 5.1 mg (equivalent: tacrolimus, qty 5 mg) - capsule - excipient ingredients: dichloromethane; lactose; magnesium stearate; croscarmellose sodium; ethanol absolute; hypromellose; titanium dioxide; purified water; iron oxide red; gelatin; sodium lauryl sulfate - tacrolimus is indicated for use as an adjunct to liver, kidney, lung or heart allograft transplantation in adults and children.